Reviewed,
UniProtKB/Swiss-Prot O88339 (EPN1_RAT)
Last modified
January 19, 2010.
Version 91.
History...
Clusters with 100%,
90%,
50% identity |
Documents (3) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Epsin-1 Alternative name(s): EPS-15-interacting protein 1 | ||
| Gene names |
| ||
| Organism | Rattus norvegicus (Rat) | ||
| Taxonomic identifier | 10116 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Rattus |
Protein attributes
| Sequence length | 575 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Binds to membranes enriched in phosphatidylinositol-4,5-biphosphate (PtdIns(4,5)P2). Modifies membrane curvature and facilitates the formation of clathrin-coated invaginations. Regulates receptor-mediated endocytosis. Ref.1 Ref.7 Ref.10 |
| Subunit structure | Monomer. Binds REPS2 and ITSN1 By similarity. Binds EPS15, clathrin, ZBTB16/ZNF145, AP2A1 and AP2A2. Binds ubiquitinated proteins. Interacts with RALBP1 in a complex also containing NUMB and TFAP2A during interphase and mitosis. Interacts with AP2B1. Ref.1 Ref.7 Ref.2 Ref.3 Ref.4 Ref.5 Ref.6 Ref.9 |
| Subcellular location | Cytoplasm. Cell membrane; Peripheral membrane protein. Nucleus. Membrane › clathrin-coated pit. Note: Associated with the cytoplasmic membrane at sites where clathrin-coated pits are forming. Colocalizes with clathrin and AP-2 in a punctate pattern on the plasma membrane. Colocalizes with clathrin at the Golgi complex. Detected in presynaptic nerve terminals and in synaptosomes. May shuttle to the nucleus when associated with ZBTB16/ZNF145. Ref.1 Ref.7 Ref.6 Ref.9 |
| Tissue specificity | Ubiquitous. Ref.1 |
| Domain | The NPF repeat domain is involved in EPS15 binding. The DPW repeat domain is involved in AP2A2 and clathrin binding. The [DE]-X(1,2)-F-X-X-[FL]-X-X-X-R motif mediates interaction the AP-2 complex subunit AP2B1 By similarity. |
| Post-translational modification | Ubiquitinated. Ref.8 Phosphorylated on serine and/or threonine residues in mitotic cells. Phosphorylation reduces interaction with REPS2, AP-2 and the membrane fraction. Depolarization of synaptosomes results in dephosphorylation. Ref.3 |
| Sequence similarities | Belongs to the epsin family. Contains 1 ENTH (epsin N-terminal homology) domain. Contains 3 UIM (ubiquitin-interacting motif) repeats. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Endocytosis |
| Cellular component | Cell membrane Coated pit Cytoplasm Membrane Nucleus |
| Domain | Repeat |
| Ligand | Lipid-binding |
| PTM | Phosphoprotein Ubl conjugation |
| Technical term | 3D-structure |
| Gene Ontology (GO) | |
| Biological process | endocytosis Ref.10 Inferred from direct assay. Source: RGD |
| Cellular component | coated pit Inferred from electronic annotation. Source: UniProtKB-SubCell cytoplasmInferred from electronic annotation. Source: UniProtKB-SubCell extrinsic to membraneInferred from electronic annotation. Source: UniProtKB-SubCell nucleusInferred from direct assay. Source: RGD plasma membraneInferred from electronic annotation. Source: UniProtKB-KW |
| Molecular function | lipid binding Inferred from electronic annotation. Source: UniProtKB-KW transcription factor bindingInferred from physical interaction. Source: RGD |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 575 | 575 | Epsin-1 | PRO_0000074515 | |||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||
| Domain | 12 – 144 | 133 | ENTH | ||||||||||||||||||||||||||||
| Repeat | 183 – 202 | 20 | UIM 1 | ||||||||||||||||||||||||||||
| Repeat | 208 – 227 | 20 | UIM 2 | ||||||||||||||||||||||||||||
| Repeat | 233 – 252 | 20 | UIM 3 | ||||||||||||||||||||||||||||
| Repeat | 274 – 276 | 3 | 1 | ||||||||||||||||||||||||||||
| Repeat | 294 – 296 | 3 | 2 | ||||||||||||||||||||||||||||
| Repeat | 306 – 308 | 3 | 3 | ||||||||||||||||||||||||||||
| Repeat | 319 – 321 | 3 | 4 | ||||||||||||||||||||||||||||
| Repeat | 332 – 334 | 3 | 5 | ||||||||||||||||||||||||||||
| Repeat | 349 – 351 | 3 | 6 | ||||||||||||||||||||||||||||
| Repeat | 367 – 369 | 3 | 7 | ||||||||||||||||||||||||||||
| Repeat | 377 – 379 | 3 | 8 | ||||||||||||||||||||||||||||
| Repeat | 501 – 503 | 3 | 1 | ||||||||||||||||||||||||||||
| Repeat | 517 – 519 | 3 | 2 | ||||||||||||||||||||||||||||
| Repeat | 571 – 573 | 3 | 3 | ||||||||||||||||||||||||||||
| Region | 274 – 379 | 106 | 8 X 3 AA repeats of D-P-W | ||||||||||||||||||||||||||||
| Region | 501 – 573 | 73 | 3 X 3 AA repeats of N-P-F | ||||||||||||||||||||||||||||
| Motif | 401 – 410 | 10 | [DE]-X(1,2)-F-X-X-[FL]-X-X-X-R motif | ||||||||||||||||||||||||||||
| Compositional bias | 267 – 572 | 306 | Ala/Gly/Pro-rich | ||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||
| Binding site | 8 | 1 | Phosphatidylinositol lipid headgroup | ||||||||||||||||||||||||||||
| Binding site | 11 | 1 | Phosphatidylinositol lipid headgroup | ||||||||||||||||||||||||||||
| Binding site | 25 | 1 | Phosphatidylinositol lipid headgroup | ||||||||||||||||||||||||||||
| Binding site | 30 | 1 | Phosphatidylinositol lipid headgroup | ||||||||||||||||||||||||||||
| Binding site | 63 | 1 | Phosphatidylinositol lipid headgroup | ||||||||||||||||||||||||||||
| Binding site | 73 | 1 | Phosphatidylinositol lipid headgroup | ||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||
| Modified residue | 382 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||||
| Modified residue | 419 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||||
| Modified residue | 434 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||||
| Modified residue | 453 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||||
| Modified residue | 459 | 1 | Phosphothreonine By similarity | ||||||||||||||||||||||||||||
| Modified residue | 463 | 1 | Phosphothreonine By similarity | ||||||||||||||||||||||||||||
| Modified residue | 469 | 1 | Phosphothreonine By similarity | ||||||||||||||||||||||||||||
| Modified residue | 493 | 1 | Phosphothreonine By similarity | ||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||
| Mutagenesis | 6 | 1 | L → E, H or Q: Reduces lipid binding. Ref.10 | ||||||||||||||||||||||||||||
| Mutagenesis | 8 | 1 | R → A: Strongly reduces lipid binding. Ref.7 | ||||||||||||||||||||||||||||
| Mutagenesis | 63 | 1 | R → L: Strongly reduces lipid binding. Abolishes lipid binding; when associated with L-73. Ref.7 Ref.10 | ||||||||||||||||||||||||||||
| Mutagenesis | 72 | 1 | R → A: Abolishes ZNF145 binding. Ref.7 | ||||||||||||||||||||||||||||
| Mutagenesis | 73 | 1 | H → L: Abolishes lipid binding; when associated with L-63. Ref.10 | ||||||||||||||||||||||||||||
| Mutagenesis | 76 | 1 | K → A: Strongly reduces lipid binding. Ref.7 | ||||||||||||||||||||||||||||
| Mutagenesis | 190 | 1 | L → A: Abolishes mono-ubiquitination. Ref.8 | ||||||||||||||||||||||||||||
| Mutagenesis | 257 – 259 | 3 | LMD → AAA: Strongly reduces clathrin binding. Ref.6 | ||||||||||||||||||||||||||||
| Mutagenesis | 260 – 263 | 4 | LADV → AAAA: Strongly reduces clathrin binding. Ref.6 | ||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||
| Helix | 2 – 11 | 10 | |||||||||||||||||||||||||||||
| Helix | 19 – 27 | 9 | |||||||||||||||||||||||||||||
| Beta strand | 30 – 33 | 4 | |||||||||||||||||||||||||||||
| Helix | 37 – 46 | 10 | |||||||||||||||||||||||||||||
| Helix | 50 – 64 | 15 | |||||||||||||||||||||||||||||
| Helix | 68 – 70 | 3 | |||||||||||||||||||||||||||||
| Helix | 71 – 87 | 17 | |||||||||||||||||||||||||||||
| Helix | 90 – 98 | 9 | |||||||||||||||||||||||||||||
| Helix | 100 – 104 | 5 | |||||||||||||||||||||||||||||
| Helix | 105 – 108 | 4 | |||||||||||||||||||||||||||||
| Helix | 120 – 135 | 16 | |||||||||||||||||||||||||||||
| Helix | 137 – 155 | 19 | |||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Epsin is an EH-domain-binding protein implicated in clathrin-mediated endocytosis." Chen H., Fre S., Slepnev V.I., Capua M.R., Takei K., Butler M.H., Di Fiore P.P., De Camilli P. Nature 394:793-797(1998) [PubMed: 9723620] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INTERACTION WITH EPS15; AP2A1 AND AP2A2. Strain: Wistar. Tissue: Brain. |
| [2] | "A structural explanation for the binding of multiple ligands by the alpha-adaptin appendage domain." Owen D.J., Vallis Y., Noble M.E.M., Hunter J.B., Dafforn T.R., Evans P.R., McMahon H.T. Cell 97:805-815(1999) [PubMed: 10380931] [Abstract] Cited for: INTERACTION WITH AP2A2. |
| [3] | "The interaction of epsin and Eps15 with the clathrin adaptor AP-2 is inhibited by mitotic phosphorylation and enhanced by stimulation-dependent dephosphorylation in nerve terminals." Chen H., Slepnev V.I., Di Fiore P.P., De Camilli P. J. Biol. Chem. 274:3257-3260(1999) [PubMed: 9920862] [Abstract] Cited for: PHOSPHORYLATION, INTERACTION WITH AP-2. |
| [4] | "Crystal structure of the alpha appendage of AP-2 reveals a recruitment platform for clathrin-coat assembly." Traub L.M., Downs M.A., Westrich J.L., Fremont D.H. Proc. Natl. Acad. Sci. U.S.A. 96:8907-8912(1999) [PubMed: 10430869] [Abstract] Cited for: INTERACTION WITH AP2A2. |
| [5] | "The structure and function of the beta 2-adaptin appendage domain." Owen D.J., Vallis Y., Pearse B.M.F., McMahon H.T., Evans P.R. EMBO J. 19:4216-4227(2000) [PubMed: 10944104] [Abstract] Cited for: INTERACTION WITH AP2B1. |
| [6] | "Epsin binds to clathrin by associating directly with the clathrin-terminal domain. Evidence for cooperative binding through two discrete sites." Drake M.T., Downs M.A., Traub L.M. J. Biol. Chem. 275:6479-6489(2000) [PubMed: 10692452] [Abstract] Cited for: MUTAGENESIS OF 257-LEU--ASP-259 AND 260-LEU--VAL-263, SUBCELLULAR LOCATION, INTERACTION WITH CLATHRIN HEAVY CHAIN AND AP-2. |
| [7] | "Role of the ENTH domain in phosphatidylinositol-4,5-bisphosphate binding and endocytosis." Itoh T., Koshiba S., Kigawa T., Kikuchi A., Yokoyama S., Takenawa T. Science 291:1047-1051(2001) [PubMed: 11161217] [Abstract] Cited for: FUNCTION, INTERACTION WITH ZBTB16, SUBCELLULAR LOCATION, MUTAGENESIS OF ARG-8; ARG-63; ARG-72 AND LYS-76. |
| [8] | "A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins." Polo S., Sigismund S., Faretta M., Guidi M., Capua M.R., Bossi G., Chen H., De Camilli P., Di Fiore P.P. Nature 416:451-455(2002) [PubMed: 11919637] [Abstract] Cited for: MUTAGENESIS OF LEU-190, UBIQUITINATION. |
| [9] | "Epsin 1 undergoes nucleocytosolic shuttling and its eps15 interactor NH(2)-terminal homology (ENTH) domain, structurally similar to Armadillo and Heat repeats, interacts with the transcription factor promyelocytic leukemia Zn(2)+ finger protein (PLZF)." Hyman J., Chen H., Di Fiore P.P., De Camilli P., Brunger A.T. J. Cell Biol. 149:537-546(2000) [PubMed: 10791968] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 12-160, SUBCELLULAR LOCATION, INTERACTION WITH ZNF145. |
| [10] | "Curvature of clathrin-coated pits driven by epsin." Ford M.G.J., Mills I.G., Peter B.J., Vallis Y., Praefcke G.J.K., Evans P.R., McMahon H.T. Nature 419:361-366(2002) [PubMed: 12353027] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 1-158 IN COMPLEX WITH INOSITOL-1,4,5-TRIPHOSPHATE, FUNCTION, MUTAGENESIS OF LEU-6; ARG-63 AND HIS-73. |
| [11] | "Accessory protein recruitment motifs in clathrin-mediated endocytosis." Brett T.J., Traub L.M., Fremont D.H. Structure 10:797-809(2002) [PubMed: 12057195] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 375-381 IN COMPLEX WITH AP2A2. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF018261 mRNA. Translation: AAC33823.1. | ||||||||||||||||||||||||||||||
| IPI | IPI00208515. | ||||||||||||||||||||||||||||||
| RefSeq | NP_476477.1. | ||||||||||||||||||||||||||||||
| UniGene | Rn.30007 | ||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||
| DisProt | DP00251. | ||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||
| STRING | O88339. | ||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||
| PhosphoSite | O88339. | ||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||
| PRIDE | O88339. | ||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||
| Ensembl | ENSRNOT00000021286; ENSRNOP00000021286; ENSRNOG00000015753; Rattus norvegicus. [Genome view] | ||||||||||||||||||||||||||||||
| GeneID | 117277. | ||||||||||||||||||||||||||||||
| KEGG | rno:117277. | ||||||||||||||||||||||||||||||
| UCSC | NM_057136. rat. | ||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||
| CTD | 117277. | ||||||||||||||||||||||||||||||
| RGD | 619772. Epn1. | ||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||
| eggNOG | roNOG13892. | ||||||||||||||||||||||||||||||
| HOVERGEN | O88339. | ||||||||||||||||||||||||||||||
| InParanoid | O88339. | ||||||||||||||||||||||||||||||
| OMA | PTSDPWG. | ||||||||||||||||||||||||||||||
| OrthoDB | EOG9SXQZ5. | ||||||||||||||||||||||||||||||
| PhylomeDB | O88339. | ||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||
| ArrayExpress | O88339. | ||||||||||||||||||||||||||||||
| Genevestigator | O88339. | ||||||||||||||||||||||||||||||
| GermOnline | ENSRNOG00000015753. Rattus norvegicus. | ||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||
| InterPro | IPR008942. ENTH_VHS. IPR013809. Epsin-like_N. IPR001026. Epsin_N. IPR003903. Ubiquitin-int_motif. [Graphical view] | ||||||||||||||||||||||||||||||
| Gene3D | G3DSA:1.25.40.90. ENTH_VHS. 1 hit. | ||||||||||||||||||||||||||||||
| Pfam | PF01417. ENTH. 1 hit. PF02809. UIM. 2 hits. [Graphical view] | ||||||||||||||||||||||||||||||
| SMART | SM00273. ENTH. 1 hit. SM00726. UIM. 3 hits. [Graphical view] | ||||||||||||||||||||||||||||||
| PROSITE | PS50942. ENTH. 1 hit. PS50330. UIM. 3 hits. [Graphical view] | ||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||
Other Resources | |||||||||||||||||||||||||||||||
| NextBio | 620217. | ||||||||||||||||||||||||||||||
Entry information
| Entry name | EPN1_RAT | ||||||||
| Accession | Primary (citable) accession number: O88339 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| Protein Spotlight Protein Spotlight articles and cited UniProtKB/Swiss-Prot entries |
| SIMILARITY comments Index of protein domains and families |

Clusters with


